Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 16, 2022
Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivoYue-Qing Wang, Cong Huang, Peng-Ju Ye, et al.
Drug Delivery|February 22, 2017
In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapyCan Huang, Na-Mei Li, Pei Gao, et al.
ACS Applied Materials & Interfaces|July 28, 2018
Fabrication of MOF Thin Films at Miscible Liquid-Liquid Interface by Spray MethodXiao-Jue Bai, Dan Chen, Lin-Lin Li, et al.
Probiotics and Antimicrobial Proteins|May 27, 2025
Screening of Fecal Bacteroides Strains and Discovery of Bacteroides eggerthii S13-F8 with Protective Effects Against Chemotherapy-Induced DiarrheaYi Zhao, Zhengqun Dai, Yanmei Lang, et al.
Nature Communications|September 13, 2023
Dual hypoxia-responsive supramolecular complex for cancer target therapyJian-Shuang Guo, Juan-Juan Li, Ze-Han Wang, et al.
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|January 18, 2014
[Clinical effect analysis of ankylosing spondylitis treated by Chinese medical syndrome differentiation]Xing-Hua Feng, Quan Jiang, Hong-Xiao Liu, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 1, 2023
Clinical Subtypes of Neutrophilic Asthma: A Cluster Analysis From Australasian Severe Asthma NetworkLi Xiu He, Ke Deng, Ji Wang, et al.
Chest|March 11, 2026
Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 in Patients with COPD in China (PACER-II): a phase 2, multicentre, randomised, double-blind, placebo-controlled trialLi-Xiu He, Ling Yang, Zu-Ke Xiao, et al.
Pageof 17